State of Tennessee, Department of Treasury’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.5M Buy
81,668
+1,295
+2% +$604K 0.12% 157
2025
Q4
$37.8M Sell
80,373
-6,388
-7% -$2.75M 0.12% 154
2025
Q3
$34M Sell
86,761
-18,998
-18% -$7.94M 0.11% 160
2025
Q2
$47.1M Buy
105,759
+7,410
+8% +$3.41M 0.17% 113
2025
Q1
$47.7M Buy
98,349
+5,160
+6% +$2.4M 0.18% 109
2024
Q4
$37.5M Sell
93,189
-7,333
-7% -$3.4M 0.14% 129
2024
Q3
$46.8M Sell
100,522
-421
-0.4% -$202K 0.16% 111
2024
Q2
$47.3M Sell
100,943
-5,742
-5% -$2.49M 0.17% 107
2024
Q1
$44.6M Sell
106,685
-7,871
-7% -$3.33M 0.16% 113
2023
Q4
$46.6M Buy
114,556
+9,005
+9% +$3.33M 0.18% 107
2023
Q3
$36.7M Sell
105,551
-87,104
-45% -$30.5M 0.15% 127
2023
Q2
$67.8M Buy
192,655
+1,687
+0.9% +$568K 0.28% 80
2023
Q1
$60.2M Buy
190,968
+15,582
+9% +$4.67M 0.27% 82
2022
Q4
$50.6M Sell
175,386
-68,077
-28% -$20.7M 0.24% 97
2022
Q3
$70.5M Sell
243,463
-9,031
-4% -$2.6M 0.34% 60
2022
Q2
$71.2M Sell
252,494
-56,485
-18% -$15.1M 0.33% 68
2022
Q1
$80.6M Buy
308,979
+65,837
+27% +$15.6M 0.31% 66
2021
Q4
$53.4M Buy
243,142
+49,402
+25% +$9.61M 0.2% 120
2021
Q3
$35.1M Sell
193,740
-175,176
-47% -$34.2M 0.14% 161
2021
Q2
$74.4M Buy
368,916
+47,692
+15% +$9.98M 0.28% 81
2021
Q1
$69M Buy
321,224
+31,996
+11% +$7.03M 0.28% 85
2020
Q4
$68.4M Sell
289,228
-175,534
-38% -$40.3M 0.29% 76
2020
Q3
$126M Buy
464,762
+211,385
+83% +$58.3M 0.59% 37
2020
Q2
$73.6M Buy
253,377
+17,227
+7% +$4.67M 0.36% 62
2020
Q1
$56.2M Buy
236,150
+58,231
+33% +$13.4M 0.32% 77
2019
Q4
$39M Buy
177,919
+14,130
+9% +$2.86M 0.17% 141
2019
Q3
$27.7M Buy
163,789
+104,770
+178% +$18.5M 0.13% 165
2019
Q2
$10.8M Sell
59,019
-4,951
-8% -$866K 0.05% 305
2019
Q1
$11.8M Sell
63,970
-2,256
-3% -$417K 0.06% 297
2018
Q4
$11M Sell
66,226
-342,797
-84% -$59.4M 0.06% 299
2018
Q3
$78.8M Buy
409,023
+135,825
+50% +$24.2M 0.38% 55
2018
Q2
$46.4M Buy
273,198
+60,108
+28% +$9.32M 0.24% 108
2018
Q1
$34.7M Buy
213,090
+26,765
+14% +$4.37M 0.18% 143
2017
Q4
$27.9M Buy
186,325
+12,727
+7% +$1.88M 0.12% 181
2017
Q3
$26.4M Buy
173,598
+80,588
+87% +$12.1M 0.13% 178
2017
Q2
$12M Sell
93,010
-41
-0% -$4.93K 0.06% 304
2017
Q1
$10.2M Buy
93,051
+15,313
+20% +$1.35M 0.05% 347
2016
Q4
$5.73M Sell
77,738
-27,225
-26% -$2.22M 0.03% 494
2016
Q3
$9.15M Sell
104,963
-126,645
-55% -$12M 0.04% 383
2016
Q2
$19.9M Sell
231,608
-4,862
-2% -$420K 0.1% 225
2016
Q1
$18.8M Buy
236,470
+201,945
+585% +$18.3M 0.11% 208
2015
Q4
$4.34M Sell
34,525
-65,058
-65% -$7.85M 0.03% 493
2015
Q3
$10.4M Sell
99,583
-16,810
-14% -$2.16M 0.06% 303
2015
Q2
$14.4M Buy
116,393
+1,303
+1% +$164K 0.08% 255
2015
Q1
$13.6M Buy
115,090
+10,150
+10% +$1.22M 0.07% 287
2014
Q4
$12.5M Sell
104,940
-3,711
-3% -$418K 0.07% 302
2014
Q3
$12.2M Buy
108,651
+68,551
+171% +$6.53M 0.07% 279
2014
Q2
$3.8M Buy
40,100
+4,300
+12% +$302K 0.02% 533
2014
Q1
$2.53M Sell
35,800
-3,600
-9% -$285K 0.01% 645
2013
Q4
$2.93M Sell
39,400
-600
-2% -$41.8K 0.02% 652
2013
Q3
$3.03M Buy
+40,000
New +$3.18M 0.02% 643

Other funds holding VRTX

State of Tennessee, Department of Treasury's VRTX Position: Q1 2026 in Review

State of Tennessee, Department of Treasury increased its Vertex Pharmaceuticals (VRTX) stake by 1.6% in Q1 2026, buying an estimated $604K and bringing the position to 81,668 shares worth $36.5M. The position accounts for 0.12% of the portfolio, ranked #157.

State of Tennessee, Department of Treasury first reported a position in VRTX in Q3 2013 and has held it in 51 quarters since. The position peaked at $126M in Q3 2020. 1,693 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • State of Tennessee, Department of Treasury held 81,668 shares of Vertex Pharmaceuticals worth $36.5M as of Q1 2026.
  • State of Tennessee, Department of Treasury bought 1,295 Vertex Pharmaceuticals shares in Q1 2026, an estimated $604K.
  • Vertex Pharmaceuticals made up 0.12% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #157 holding.
  • State of Tennessee, Department of Treasury first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 51 quarters since.
  • State of Tennessee, Department of Treasury's Vertex Pharmaceuticals position peaked at $126M in Q3 2020.
  • 1,693 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.